Education
About Us
Working with TipRanks
Follow Us
AFC-HD AMS Life Science Co., Ltd. (JP:2927)
:2927
Total Valuation
AFC-HD AMS Life Science Co., Ltd. has a market cap or net worth of ¥12.24B. The enterprise value is ¥25.18B.
Market Cap¥12.24B
Enterprise Value¥25.18B
Share Statistics
AFC-HD AMS Life Science Co., Ltd. has 14,411,199 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,411,199
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AFC-HD AMS Life Science Co., Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee32.85M
Profits Per Employee1.46M
Employee Count994
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of AFC-HD AMS Life Science Co., Ltd. is 8.5. AFC-HD AMS Life Science Co., Ltd.’s PEG ratio is 0.70.
PE Ratio8.5
PS Ratio0.39
PB Ratio0.84
Price to Fair Value―
Price to FCF-6.28
Price to Operating Cash Flow0.00
PEG Ratio0.70
Income Statement
In the last 12 months, AFC-HD AMS Life Science Co., Ltd. had revenue of 32.66B and earned 1.45B in profits. Earnings per share was 102.98.
Revenue32.66B
Gross Profit10.97B
Operating Income2.38B
Pretax Income2.20B
Net Income1.45B
EBITDA3.80B
Earnings Per Share (EPS)102.98
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
AFC-HD AMS Life Science Co., Ltd. pays an annual dividend of ¥18, resulting in a dividend yield of 3.94%
Dividend Per Share¥18
Dividend Yield3.94%
Payout Ratio33.02%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change9.18%
50-Day Moving Average862.16
200-Day Moving Average850.48
Relative Strength Index (RSI)57.43
Average Volume (3m)18.87K
Important Dates
AFC-HD AMS Life Science Co., Ltd. upcoming earnings date is Jan 14, 2026, TBA (Confirmed).
Last Earnings DateOct 15, 2025
Next Earnings DateJan 14, 2026
Ex-Dividend Date―
Financial Position
AFC-HD AMS Life Science Co., Ltd. as a current ratio of ―, with Debt / Equity ratio of 162.80%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, AFC-HD AMS Life Science Co., Ltd. has paid 732.20M in taxes.
Income Tax732.20M
Effective Tax Rate―
Enterprise Valuation
AFC-HD AMS Life Science Co., Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
AFC-HD AMS Life Science Co., Ltd. has ¥11.34B in cash and marketable securities with ¥24.29B in debt, giving a net cash position of -¥12.95B billion.
Cash & Marketable Securities¥11.34B
Total Debt¥24.29B
Net Cash-¥12.95B
Net Cash Per Share-¥898.55
Tangible Book Value Per Share―
Margins
Gross margin is 33.69%, with operating margin of ―, and net profit margin of ―.
Gross Margin33.69%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for AFC-HD AMS Life Science Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.47%
EPS Growth Forecast29.21%